Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
出版年份 2019 全文链接
标题
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
作者
关键词
-
出版物
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume -, Issue -, Pages 1-10
出版商
Informa UK Limited
发表日期
2019-07-08
DOI
10.1080/21678421.2019.1632346
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study
- (2017) Olivier Lortholary et al. LANCET
- Amyotrophic lateral sclerosis
- (2017) Michael A van Es et al. LANCET
- Edaravone: a new treatment for ALS on the horizon?
- (2017) Orla Hardiman et al. LANCET NEUROLOGY
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
- (2017) Dmitry Petrov et al. Frontiers in Aging Neuroscience
- Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression
- (2017) Benjamin J. Murdock et al. JAMA Neurology
- Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes
- (2017) Weihua Zhao et al. JAMA Neurology
- A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis
- (2017) Johnathan Cooper-Knock et al. Acta Neuropathologica Communications
- Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
- (2016) Emiliano Trias et al. Journal of Neuroinflammation
- Projected increase in amyotrophic lateral sclerosis from 2015 to 2040
- (2016) Karissa C. Arthur et al. Nature Communications
- The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset
- (2016) Malcolm Proudfoot et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Rate of disease progression: a prognostic biomarker in ALS
- (2015) Julie Labra et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient
- (2015) Maria Salvado WORLD JOURNAL OF GASTROENTEROLOGY
- Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
- (2012) Patrick Vermersch et al. BMC Neurology
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
- (2012) Jenny S. Henkel et al. EMBO Molecular Medicine
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
- (2011) François Piette et al. Alzheimers Research & Therapy
- Clinical significance in the change of decline in ALSFRS-R
- (2010) Carmen Castrillo-Viguera et al. Amyotrophic Lateral Sclerosis
- The epidemiology and treatment of ALS: Focus on the heterogeneity of the disease and critical appraisal of therapeutic trials
- (2010) Ettore Beghi et al. Amyotrophic Lateral Sclerosis
- Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2010) Swati P Aggarwal et al. LANCET NEUROLOGY
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
- (2009) Patrice Dubreuil et al. PLoS One
- ALSFRS-R score and its ratio: A useful predictor for ALS-progression
- (2008) Katja Kollewe et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started